Amyotrophic Lateral Sclerosis (ALS)

Sponsored diagnostic testing programs for Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle weakness and loss of function. While most cases are sporadic, some are linked to inherited variants, making genetic evaluation useful for diagnosis, care planning, and identifying research opportunities.

1 program found for Amyotrophic Lateral Sclerosis (ALS)

Programs

1 program
Amyotrophic Lateral Sclerosis (ALS)
ALS Identified
Sponsored by
Biogen

Invitae Amyotrophic Lateral Sclerosis with C9orf72 Panel

The ALS Identified Program enables clinicians in the US and Puerto Rico to access a broad genetic test for patients with diagnosed or familial ALS, at no cost. This program supports diagnostic clarity, helps inform prognosis and care planning, and can facilitate family counseling or trial eligibility. All costs are covered — there is no charge to the patient, provider, or payer.

Neurology
ViewOrder
Performing labInvitae | Labcorp